top of page

In the next 10 years, 150+ drugs will come off patent protection. These drugs are worth over $100 Billion in sales.

Our Mission

Laxxon Medical is dedicated to engineering patented 3D pharmaceutical solutions which optimize products and benefit patients.

​

The basis of Laxxon's pharmaceutical solutions is our cutting-edge 3D screen printing technology and the extensive intellectual property surrounding it.

​

Our commitment to innovation and health is fueled by the expertise, integrity, agility, and diversity of the Laxxon team.

 

Laxxon strives to accelerate pharmaceutical progress globally by establishing ourselves as the leader in the field of 3D printed drugs.

Laxxon and CU Innovations Establish Partnership at Anschutz Medical Campus

Laxxon Announces Formation of Renowned Scientific Advisory Board

CSO Achim Schneeberger Discusses LXM.5, Laxxon’s New Generation Levodopa

Laxxon Establishes Partnership with CDMO Hovione

Laxxon 3D Screen Printing Technology Enables Fabrication of Oral Drug Dosage Forms

Patent Extension

Advanced Patented Generics

New Drug Development

Our Solutions

3D Printed Pharmaceutical Solutions for Patients

& Partners

Advanced Patented Generics, Patent Extension,

& New Drug Development

Laxxon Medical is dedicated to engineering patented 3D pharmaceutical solutions which optimize products and benefit patients.

The basis of Laxxon’s pharmaceutical solutions is our cutting-edge 3D screen printing technology and the extensive intellectual property surrounding it. 

​

Laxxon strives to accelerate pharmaceutical progress globally by establishing ourselves as the leader in the field of 3D printed drugs. 

IMG_0261 copy_edited.jpg

In the next 10 years, 150+ drugs will come off patent protection. These drugs are worth over $100 Billion in sales.

Laxxon has both an external pipeline and in-house Advanced Patented Generic pipeline.

03.

Pipeline consists of 13 in-house products and 3 products that are being developed for external clients

All products created with our SPID®-Technology manufacturing approach are patent protected, 

whether engineered in-house or with an external partner

bottom of page